Wnt family ligands

STAT3-IN-12 is a potent STAT3 signal inhibitor that can inhibit IL-6 induced JAK/STAT3 signalling pathway activation. STAT3-IN-12 inhibits cancer cell growth, migration, and induce cell apoptosis as well as cycle arrest. STAT3-IN-12 can be used in

STAT3-IN-12 is a potent STAT3 signal inhibitor that can inhibit IL-6 induced JAK/STAT3 signalling pathway activation. STAT3-IN-12 inhibits cancer cell growth, migration, and induce cell apoptosis as well as cycle arrest. STAT3-IN-12 can be used in

STAT3-IN-12 is a potent STAT3 signal inhibitor that can inhibit IL-6 induced JAK/STAT3 signalling pathway activation. STAT3-IN-12 inhibits cancer cell growth, migration, and induce cell apoptosis as well as cycle arrest. STAT3-IN-12 can be used in

STAT3-IN-12 is a potent STAT3 signal inhibitor that can inhibit IL-6 induced JAK/STAT3 signalling pathway activation. STAT3-IN-12 inhibits cancer cell growth, migration, and induce cell apoptosis as well as cycle arrest. STAT3-IN-12 can be used in

STAT3-IN-3 is a potent and selective inhibitor of signal transducer and activator of transcription 3 (STAT3) , with anti-proliferative activity. STAT3-IN-3 induces apoptosis in breast cancer cells. STAT3-IN-3 acts as a promising

STAT3-IN-3 is a potent and selective inhibitor of signal transducer and activator of transcription 3 (STAT3) , with anti-proliferative activity. STAT3-IN-3 induces apoptosis in breast cancer cells. STAT3-IN-3 acts as a promising

STAT3-IN-3 is a potent and selective inhibitor of signal transducer and activator of transcription 3 (STAT3) , with anti-proliferative activity. STAT3-IN-3 induces apoptosis in breast cancer cells. STAT3-IN-3 acts as a promising

STAT3-IN-3 is a potent and selective inhibitor of signal transducer and activator of transcription 3 (STAT3) , with anti-proliferative activity. STAT3-IN-3 induces apoptosis in breast cancer cells. STAT3-IN-3 acts as a promising

STAT3-IN-3 is a potent and selective inhibitor of signal transducer and activator of transcription 3 (STAT3) , with anti-proliferative activity. STAT3-IN-3 induces apoptosis in breast cancer cells. STAT3-IN-3 acts as a promising

STAT5-IN-2 is a STAT5 inhibitor,STAT5-IN-2 has potent antileukemic effectIn VitroSTAT5-IN-2 has EC 50 values of 9 μM and 5 μM in K562 and KU812 cells, respectively. STAT5-IN-2 (100 nM-50 µM 48 hours) has EC 50 values of 2.6 µM and 3.5 µM in KG1a

STAT5-IN-2 is a STAT5 inhibitor,STAT5-IN-2 has potent antileukemic effectIn VitroSTAT5-IN-2 has EC 50 values of 9 μM and 5 μM in K562 and KU812 cells, respectively. STAT5-IN-2 (100 nM-50 µM 48 hours) has EC 50 values of 2.6 µM and 3.5 µM in KG1a

STAT5-IN-2 is a STAT5 inhibitor,STAT5-IN-2 has potent antileukemic effectIn VitroSTAT5-IN-2 has EC 50 values of 9 μM and 5 μM in K562 and KU812 cells, respectively. STAT5-IN-2 (100 nM-50 µM 48 hours) has EC 50 values of 2.6 µM and 3.5 µM in KG1a